5-methoxytryptamine has been researched along with mevastatin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamblin, MW; Sjögren, B; Svenningsson, P | 1 |
1 other study(ies) available for 5-methoxytryptamine and mevastatin
Article | Year |
---|---|
Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors.
Topics: 5-Methoxytryptamine; Activating Transcription Factor 1; beta-Cyclodextrins; Binding, Competitive; Blotting, Western; Cholesterol; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Fumonisins; HeLa Cells; Humans; Lovastatin; Mevalonic Acid; Phenols; Phosphorylation; Radioligand Assay; Receptors, Serotonin; Serine; Serotonin; Signal Transduction; Sulfonamides; Transfection; Tritium | 2006 |